Gene Symbol | Gene ID | Gene Info |
---|---|---|
HMX3
|
ENSG00000188620.9 | H6 family homeobox 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_124899981_124900411 | HMX3 | 4718 | 0.192663 | 0.84 | 4.4e-03 | Click! |
chr10_124894858_124895242 | HMX3 | 428 | 0.824427 | 0.67 | 4.7e-02 | Click! |
chr10_124893236_124893406 | HMX3 | 2157 | 0.289133 | 0.64 | 6.6e-02 | Click! |
chr10_124897218_124897579 | HMX3 | 1920 | 0.310093 | 0.63 | 6.9e-02 | Click! |
chr10_124899658_124899809 | HMX3 | 4255 | 0.199391 | 0.58 | 1.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_90218630_90219104 | 1.54 |
GPRIN3 |
GPRIN family member 3 |
10294 |
0.3 |
chr7_8166102_8166400 | 1.42 |
AC006042.6 |
|
12596 |
0.21 |
chr14_62163629_62164039 | 1.36 |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
506 |
0.84 |
chr2_26018726_26019025 | 1.32 |
ASXL2 |
additional sex combs like 2 (Drosophila) |
15697 |
0.23 |
chrX_13021754_13022013 | 1.30 |
TMSB4X |
thymosin beta 4, X-linked |
28106 |
0.19 |
chr9_92108756_92109116 | 1.29 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
3411 |
0.27 |
chr4_84134465_84134616 | 1.25 |
COQ2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
71378 |
0.1 |
chr3_112183882_112184126 | 1.24 |
BTLA |
B and T lymphocyte associated |
34201 |
0.19 |
chr10_7554785_7554936 | 1.24 |
RP11-385N23.1 |
|
20309 |
0.21 |
chr11_128173540_128173801 | 1.23 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
201619 |
0.03 |
chr9_92064048_92064363 | 1.22 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
6663 |
0.26 |
chr2_158276348_158276584 | 1.14 |
CYTIP |
cytohesin 1 interacting protein |
19460 |
0.2 |
chr2_62435329_62435921 | 1.13 |
ENSG00000266097 |
. |
2664 |
0.25 |
chr1_117048262_117048434 | 1.08 |
CD58 |
CD58 molecule |
38864 |
0.12 |
chr21_35305571_35305790 | 1.06 |
LINC00649 |
long intergenic non-protein coding RNA 649 |
2162 |
0.26 |
chr1_169674701_169674897 | 1.06 |
SELL |
selectin L |
6040 |
0.21 |
chr1_224590284_224590552 | 1.06 |
ENSG00000266618 |
. |
4405 |
0.19 |
chr8_27223358_27224128 | 1.04 |
PTK2B |
protein tyrosine kinase 2 beta |
14425 |
0.22 |
chr20_57723034_57723340 | 1.03 |
ZNF831 |
zinc finger protein 831 |
42888 |
0.16 |
chr17_30683177_30683478 | 1.03 |
ZNF207 |
zinc finger protein 207 |
5400 |
0.15 |
chr7_110649129_110649323 | 1.02 |
ENSG00000221279 |
. |
80852 |
0.1 |
chr7_37479339_37479814 | 1.01 |
ENSG00000201566 |
. |
4858 |
0.21 |
chr11_73691666_73692195 | 0.99 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
53 |
0.97 |
chr1_111762611_111763176 | 0.99 |
CHI3L2 |
chitinase 3-like 2 |
6745 |
0.14 |
chr3_59436048_59436247 | 0.98 |
C3orf67 |
chromosome 3 open reading frame 67 |
400337 |
0.01 |
chr18_60870695_60870846 | 0.98 |
ENSG00000238988 |
. |
8872 |
0.24 |
chr15_62148914_62149135 | 0.98 |
RP11-16B9.1 |
|
22073 |
0.23 |
chr15_60872055_60872206 | 0.97 |
RORA |
RAR-related orphan receptor A |
12610 |
0.21 |
chr8_61708850_61709103 | 0.96 |
RP11-33I11.2 |
|
13189 |
0.27 |
chr19_9419086_9419237 | 0.95 |
ZNF699 |
zinc finger protein 699 |
1088 |
0.37 |
chr14_61870595_61870929 | 0.94 |
PRKCH |
protein kinase C, eta |
13350 |
0.24 |
chr19_15573327_15573521 | 0.94 |
RASAL3 |
RAS protein activator like 3 |
1958 |
0.22 |
chr6_159439729_159439953 | 0.94 |
RP1-111C20.4 |
|
7137 |
0.19 |
chr14_91534430_91534736 | 0.92 |
C14orf159 |
chromosome 14 open reading frame 159 |
7407 |
0.17 |
chr5_130637450_130637601 | 0.92 |
CDC42SE2 |
CDC42 small effector 2 |
37732 |
0.21 |
chr2_191740225_191740572 | 0.91 |
GLS |
glutaminase |
5155 |
0.23 |
chr4_83134392_83134548 | 0.91 |
ENSG00000202485 |
. |
38770 |
0.2 |
chr7_8054101_8054380 | 0.91 |
AC006042.7 |
|
44706 |
0.13 |
chr5_169709535_169709686 | 0.90 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
15279 |
0.21 |
chr1_160576647_160576798 | 0.90 |
CD84 |
CD84 molecule |
27416 |
0.12 |
chr14_98871416_98871598 | 0.90 |
ENSG00000241757 |
. |
53506 |
0.16 |
chr11_102175134_102175285 | 0.90 |
ENSG00000212466 |
. |
9244 |
0.18 |
chr17_1775725_1776037 | 0.90 |
RPA1 |
replication protein A1, 70kDa |
6448 |
0.16 |
chr2_152279410_152279561 | 0.89 |
RIF1 |
RAP1 interacting factor homolog (yeast) |
12881 |
0.2 |
chr17_37970513_37970744 | 0.89 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
36150 |
0.11 |
chr2_85009888_85010121 | 0.89 |
DUXAP1 |
double homeobox A pseudogene 1 |
32111 |
0.19 |
chr9_71633765_71634208 | 0.89 |
PRKACG |
protein kinase, cAMP-dependent, catalytic, gamma |
4947 |
0.24 |
chr6_53172995_53173285 | 0.88 |
ENSG00000264056 |
. |
31349 |
0.15 |
chr14_98654810_98655207 | 0.88 |
ENSG00000222066 |
. |
143079 |
0.05 |
chr13_37632850_37633317 | 0.88 |
SUPT20H |
suppressor of Ty 20 homolog (S. cerevisiae) |
486 |
0.79 |
chr2_32159791_32160047 | 0.88 |
ENSG00000221326 |
. |
14901 |
0.19 |
chr12_120445548_120445820 | 0.88 |
CCDC64 |
coiled-coil domain containing 64 |
18011 |
0.19 |
chr1_100866866_100867158 | 0.87 |
ENSG00000216067 |
. |
22681 |
0.18 |
chr17_76752517_76752856 | 0.87 |
CYTH1 |
cytohesin 1 |
19714 |
0.17 |
chr11_121328365_121328666 | 0.86 |
RP11-730K11.1 |
|
4793 |
0.26 |
chr6_41997070_41997265 | 0.86 |
ENSG00000206875 |
. |
10915 |
0.15 |
chr11_128569330_128569763 | 0.85 |
SENCR |
smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA |
3628 |
0.22 |
chr1_175177154_175177359 | 0.85 |
KIAA0040 |
KIAA0040 |
15177 |
0.25 |
chr3_18477206_18477357 | 0.85 |
SATB1 |
SATB homeobox 1 |
536 |
0.8 |
chr17_14054887_14055038 | 0.85 |
ENSG00000252305 |
. |
25486 |
0.19 |
chr6_106737124_106737275 | 0.85 |
ENSG00000244710 |
. |
5613 |
0.2 |
chr1_160610392_160610892 | 0.84 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
6169 |
0.17 |
chr10_90591338_90591536 | 0.84 |
ANKRD22 |
ankyrin repeat domain 22 |
20138 |
0.16 |
chr11_74986567_74986718 | 0.84 |
ARRB1 |
arrestin, beta 1 |
3101 |
0.18 |
chr5_130611544_130611887 | 0.84 |
CDC42SE2 |
CDC42 small effector 2 |
11922 |
0.28 |
chr18_5058444_5058595 | 0.84 |
ENSG00000222463 |
. |
70351 |
0.13 |
chr1_205742888_205743106 | 0.84 |
RAB7L1 |
RAB7, member RAS oncogene family-like 1 |
1364 |
0.37 |
chr4_39364717_39364868 | 0.84 |
RFC1 |
replication factor C (activator 1) 1, 145kDa |
3177 |
0.21 |
chr8_10982052_10982333 | 0.84 |
AF131215.3 |
|
1382 |
0.32 |
chr14_106327072_106327522 | 0.84 |
ENSG00000265714 |
. |
1273 |
0.08 |
chr17_14099361_14099532 | 0.83 |
AC005224.2 |
|
14359 |
0.19 |
chr8_129551445_129551700 | 0.83 |
ENSG00000221351 |
. |
280468 |
0.01 |
chr15_60958672_60958823 | 0.83 |
RP11-219B17.2 |
|
15021 |
0.21 |
chr21_46337804_46338132 | 0.82 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
2802 |
0.14 |
chr7_22714976_22715127 | 0.82 |
AC002480.5 |
|
13640 |
0.18 |
chr10_65033091_65033545 | 0.82 |
JMJD1C |
jumonji domain containing 1C |
4336 |
0.32 |
chr8_124099579_124099969 | 0.82 |
TBC1D31 |
TBC1 domain family, member 31 |
6127 |
0.18 |
chr12_67972561_67972821 | 0.82 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
69427 |
0.13 |
chr5_169693701_169693941 | 0.82 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
479 |
0.84 |
chr5_86580350_86580507 | 0.82 |
ENSG00000241243 |
. |
9862 |
0.17 |
chr10_22917148_22917404 | 0.82 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
36634 |
0.22 |
chr6_128256544_128256695 | 0.81 |
THEMIS |
thymocyte selection associated |
16843 |
0.26 |
chr2_69139347_69139589 | 0.81 |
GKN2 |
gastrokine 2 |
40544 |
0.13 |
chr17_58679132_58679322 | 0.80 |
PPM1D |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
1683 |
0.35 |
chr4_153320237_153320432 | 0.80 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
12696 |
0.24 |
chr15_20844526_20844677 | 0.80 |
IGHV1OR15-6 |
immunoglobulin heavy variable 1/OR15-6 (pseudogene) |
593 |
0.75 |
chr20_37432775_37433181 | 0.79 |
PPP1R16B |
protein phosphatase 1, regulatory subunit 16B |
1370 |
0.43 |
chr13_28015570_28015856 | 0.79 |
MTIF3 |
mitochondrial translational initiation factor 3 |
8613 |
0.17 |
chr17_36002739_36002995 | 0.79 |
RP11-697E22.2 |
|
109 |
0.89 |
chr11_128196527_128196678 | 0.79 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
178687 |
0.03 |
chr12_93827062_93827301 | 0.79 |
UBE2N |
ubiquitin-conjugating enzyme E2N |
7851 |
0.16 |
chr4_105888170_105888391 | 0.78 |
ENSG00000251906 |
. |
7539 |
0.31 |
chr9_33841783_33842038 | 0.78 |
ENSG00000200834 |
. |
10934 |
0.12 |
chr14_61808449_61808621 | 0.78 |
PRKCH |
protein kinase C, eta |
2425 |
0.31 |
chr17_33592921_33593072 | 0.78 |
SLFN5 |
schlafen family member 5 |
22888 |
0.14 |
chr4_10672427_10672666 | 0.78 |
CLNK |
cytokine-dependent hematopoietic cell linker |
13840 |
0.31 |
chr8_101821050_101821454 | 0.78 |
ENSG00000222795 |
. |
22836 |
0.16 |
chr9_20506939_20507440 | 0.78 |
ENSG00000264941 |
. |
4849 |
0.26 |
chr17_37116490_37116784 | 0.77 |
FBXO47 |
F-box protein 47 |
7018 |
0.14 |
chr14_31092029_31092201 | 0.77 |
SCFD1 |
sec1 family domain containing 1 |
577 |
0.79 |
chr6_35267216_35267500 | 0.77 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1729 |
0.34 |
chr16_74634733_74635049 | 0.76 |
GLG1 |
golgi glycoprotein 1 |
6101 |
0.24 |
chr4_100739674_100739989 | 0.76 |
DAPP1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
1828 |
0.43 |
chr22_36550343_36550563 | 0.76 |
APOL3 |
apolipoprotein L, 3 |
6378 |
0.24 |
chr2_173299021_173299521 | 0.76 |
AC078883.4 |
|
5940 |
0.19 |
chr14_22999356_22999596 | 0.76 |
TRAJ15 |
T cell receptor alpha joining 15 |
896 |
0.43 |
chr19_34758530_34758681 | 0.76 |
KIAA0355 |
KIAA0355 |
13103 |
0.21 |
chr2_233939464_233939700 | 0.76 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
14393 |
0.19 |
chr13_114914753_114915138 | 0.76 |
RASA3 |
RAS p21 protein activator 3 |
16859 |
0.2 |
chr3_59997046_59997753 | 0.76 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
39816 |
0.23 |
chr2_99279276_99279650 | 0.75 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
473 |
0.84 |
chr16_79305361_79305684 | 0.75 |
ENSG00000222244 |
. |
7171 |
0.31 |
chr18_29621846_29622219 | 0.75 |
ENSG00000265063 |
. |
18920 |
0.13 |
chr17_39494241_39494487 | 0.75 |
KRT33A |
keratin 33A |
12700 |
0.08 |
chr7_50350560_50351095 | 0.75 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
2509 |
0.41 |
chr5_56121216_56121683 | 0.75 |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
10048 |
0.18 |
chr7_151048881_151049036 | 0.75 |
NUB1 |
negative regulator of ubiquitin-like proteins 1 |
6527 |
0.16 |
chr4_110571544_110571753 | 0.74 |
AC004067.5 |
|
41512 |
0.14 |
chr12_92796420_92796828 | 0.74 |
RP11-693J15.4 |
|
18683 |
0.18 |
chr11_85410603_85411096 | 0.74 |
CCDC89 |
coiled-coil domain containing 89 |
13529 |
0.15 |
chr10_102271336_102271663 | 0.74 |
SEC31B |
SEC31 homolog B (S. cerevisiae) |
8092 |
0.16 |
chr5_39180395_39180675 | 0.74 |
FYB |
FYN binding protein |
22594 |
0.24 |
chr1_229168669_229168958 | 0.74 |
RP5-1061H20.5 |
|
194496 |
0.02 |
chr14_61809956_61810279 | 0.73 |
PRKCH |
protein kinase C, eta |
843 |
0.65 |
chr2_175357379_175357659 | 0.73 |
GPR155 |
G protein-coupled receptor 155 |
5697 |
0.21 |
chr5_102897922_102898150 | 0.73 |
NUDT12 |
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
454 |
0.91 |
chr18_47313047_47313239 | 0.73 |
ACAA2 |
acetyl-CoA acyltransferase 2 |
24758 |
0.13 |
chr1_121293995_121294146 | 0.73 |
FCGR1B |
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
358133 |
0.01 |
chr1_29244875_29245026 | 0.73 |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
3859 |
0.22 |
chr2_32036582_32036828 | 0.73 |
ENSG00000238448 |
. |
1348 |
0.49 |
chr2_8655283_8655712 | 0.73 |
AC011747.7 |
|
160399 |
0.04 |
chr14_99702124_99702472 | 0.73 |
AL109767.1 |
|
26987 |
0.19 |
chr8_82008774_82009156 | 0.73 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
15338 |
0.28 |
chr1_111329003_111329562 | 0.72 |
ENSG00000199710 |
. |
22154 |
0.2 |
chr18_77195690_77195983 | 0.72 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
35444 |
0.19 |
chr7_142420697_142420892 | 0.72 |
PRSS1 |
protease, serine, 1 (trypsin 1) |
36525 |
0.15 |
chr17_8340253_8340508 | 0.72 |
NDEL1 |
nudE neurodevelopment protein 1-like 1 |
968 |
0.46 |
chr22_43421246_43421514 | 0.72 |
PACSIN2 |
protein kinase C and casein kinase substrate in neurons 2 |
10229 |
0.18 |
chr22_40724161_40724445 | 0.71 |
ADSL |
adenylosuccinate lyase |
18204 |
0.18 |
chr19_50005184_50005425 | 0.71 |
ENSG00000207782 |
. |
1179 |
0.17 |
chr4_103444307_103444557 | 0.71 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
19900 |
0.19 |
chr22_40509849_40510000 | 0.71 |
TNRC6B |
trinucleotide repeat containing 6B |
64005 |
0.11 |
chr5_130709819_130709970 | 0.71 |
CDC42SE2 |
CDC42 small effector 2 |
11405 |
0.3 |
chr16_80690009_80690168 | 0.71 |
ENSG00000265341 |
. |
9372 |
0.18 |
chr3_121377371_121377908 | 0.71 |
HCLS1 |
hematopoietic cell-specific Lyn substrate 1 |
2106 |
0.24 |
chr16_15732947_15733123 | 0.71 |
KIAA0430 |
KIAA0430 |
3310 |
0.16 |
chr1_76733623_76733774 | 0.71 |
ST6GALNAC3 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
193294 |
0.03 |
chr11_60834006_60834157 | 0.71 |
CD5 |
CD5 molecule |
35786 |
0.12 |
chr11_34269165_34269316 | 0.71 |
ENSG00000201867 |
. |
58519 |
0.14 |
chr13_46741274_46741762 | 0.71 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
1136 |
0.43 |
chr10_5339048_5339261 | 0.70 |
AKR1C7P |
aldo-keto reductase family 1, member C7, pseudogene |
8721 |
0.21 |
chr12_94599434_94599688 | 0.70 |
RP11-74K11.2 |
|
19741 |
0.19 |
chr7_142903419_142903570 | 0.70 |
TAS2R40 |
taste receptor, type 2, member 40 |
15636 |
0.11 |
chr3_107279086_107279237 | 0.70 |
BBX |
bobby sox homolog (Drosophila) |
34912 |
0.24 |
chr1_110047727_110047978 | 0.70 |
AMIGO1 |
adhesion molecule with Ig-like domain 1 |
4452 |
0.12 |
chr2_109248701_109248964 | 0.70 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
11110 |
0.23 |
chr10_30790292_30790443 | 0.70 |
ENSG00000239744 |
. |
54466 |
0.13 |
chr11_108110555_108110724 | 0.70 |
ENSG00000206967 |
. |
10308 |
0.16 |
chr9_98486374_98486879 | 0.70 |
DKFZP434H0512 |
Protein LOC100506667; Putative uncharacterized protein DKFZp434H0512 |
47979 |
0.17 |
chr4_109036061_109036413 | 0.70 |
LEF1 |
lymphoid enhancer-binding factor 1 |
51220 |
0.14 |
chrX_149646217_149646416 | 0.70 |
MAMLD1 |
mastermind-like domain containing 1 |
7036 |
0.24 |
chr5_72148296_72148452 | 0.69 |
TNPO1 |
transportin 1 |
4363 |
0.23 |
chr17_38001971_38002160 | 0.69 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
18314 |
0.13 |
chr9_20256564_20257102 | 0.69 |
ENSG00000221744 |
. |
38169 |
0.2 |
chr7_142955680_142955839 | 0.69 |
GSTK1 |
glutathione S-transferase kappa 1 |
4763 |
0.11 |
chr11_13944070_13944221 | 0.69 |
ENSG00000201856 |
. |
15008 |
0.29 |
chr1_169665494_169666108 | 0.69 |
SELL |
selectin L |
15038 |
0.19 |
chr1_29291606_29291930 | 0.69 |
ENSG00000206704 |
. |
20454 |
0.19 |
chr16_67017997_67018148 | 0.69 |
CES4A |
carboxylesterase 4A |
4420 |
0.13 |
chr8_41855607_41855758 | 0.69 |
KAT6A |
K(lysine) acetyltransferase 6A |
39801 |
0.15 |
chr6_16713160_16713355 | 0.69 |
RP1-151F17.1 |
|
48112 |
0.16 |
chr21_32542516_32542707 | 0.69 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
40072 |
0.2 |
chr7_76984255_76984448 | 0.69 |
GSAP |
gamma-secretase activating protein |
24667 |
0.21 |
chr3_71265807_71265958 | 0.69 |
FOXP1 |
forkhead box P1 |
18350 |
0.27 |
chr4_90225162_90225490 | 0.68 |
GPRIN3 |
GPRIN family member 3 |
3835 |
0.36 |
chr16_3623403_3623748 | 0.68 |
NLRC3 |
NLR family, CARD domain containing 3 |
3817 |
0.17 |
chr5_55457093_55457244 | 0.68 |
ENSG00000223003 |
. |
14495 |
0.19 |
chr3_195251732_195251945 | 0.68 |
ENSG00000252620 |
. |
1819 |
0.31 |
chr1_117281810_117282316 | 0.68 |
CD2 |
CD2 molecule |
14944 |
0.19 |
chr2_162808795_162809052 | 0.68 |
ENSG00000253046 |
. |
33631 |
0.21 |
chr2_68445452_68445729 | 0.68 |
ENSG00000216115 |
. |
11468 |
0.14 |
chr10_11219483_11219897 | 0.68 |
RP3-323N1.2 |
|
6351 |
0.23 |
chr4_48134003_48134340 | 0.68 |
TXK |
TXK tyrosine kinase |
2102 |
0.27 |
chr1_234306430_234306713 | 0.68 |
SLC35F3 |
solute carrier family 35, member F3 |
43446 |
0.14 |
chr3_151918042_151918282 | 0.68 |
MBNL1 |
muscleblind-like splicing regulator 1 |
67667 |
0.12 |
chr2_68606940_68607120 | 0.68 |
AC015969.3 |
|
14314 |
0.17 |
chr7_36211224_36211417 | 0.68 |
EEPD1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
18443 |
0.21 |
chr10_121052972_121053123 | 0.68 |
RP11-79M19.2 |
|
42647 |
0.13 |
chr4_153020620_153020907 | 0.68 |
ENSG00000253077 |
. |
127998 |
0.05 |
chr14_106641300_106641451 | 0.68 |
IGHV1-18 |
immunoglobulin heavy variable 1-18 |
681 |
0.33 |
chr15_101137681_101138105 | 0.68 |
LINS |
lines homolog (Drosophila) |
752 |
0.57 |
chrX_13773144_13773358 | 0.68 |
OFD1 |
oral-facial-digital syndrome 1 |
20387 |
0.16 |
chrX_48773283_48773434 | 0.68 |
PIM2 |
pim-2 oncogene |
346 |
0.76 |
chr20_1639893_1640044 | 0.68 |
SIRPG |
signal-regulatory protein gamma |
1543 |
0.32 |
chr10_121045737_121046107 | 0.67 |
RP11-79M19.2 |
|
49772 |
0.11 |
chr14_22637586_22637737 | 0.67 |
ENSG00000238634 |
. |
26774 |
0.24 |
chr5_54391771_54392054 | 0.67 |
GZMA |
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
6564 |
0.16 |
chr2_99084461_99084735 | 0.67 |
INPP4A |
inositol polyphosphate-4-phosphatase, type I, 107kDa |
23185 |
0.21 |
chr3_195118574_195118757 | 0.67 |
ENSG00000207368 |
. |
21610 |
0.19 |
chr2_20539071_20539228 | 0.67 |
PUM2 |
pumilio RNA-binding family member 2 |
11233 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.7 | 0.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.6 | 1.9 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.6 | 1.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.6 | 1.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.6 | 1.3 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.6 | 1.8 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.6 | 1.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.6 | 2.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.6 | 2.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 1.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 2.0 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 3.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 1.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 1.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.4 | 3.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.4 | 2.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 1.8 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.4 | 1.8 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.4 | 1.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 1.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 1.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 1.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.7 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.3 | 1.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 1.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 1.0 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.3 | 0.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 1.5 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.3 | 0.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 22.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.3 | 0.9 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.3 | 0.9 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.3 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.8 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 0.6 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.3 | 0.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.8 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.3 | 0.8 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 0.8 | GO:0070266 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.3 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 1.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.5 | GO:0043368 | positive T cell selection(GO:0043368) |
0.3 | 1.8 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.3 | 1.0 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 2.4 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 1.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 0.7 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 1.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 0.9 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 2.8 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 0.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.7 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 0.2 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
0.2 | 1.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 0.6 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.2 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.2 | 0.9 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.2 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.4 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 1.2 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.2 | 0.6 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 0.6 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.2 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.2 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.4 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 1.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.4 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.2 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.6 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 1.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 0.6 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 1.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.2 | 0.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 2.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.4 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 2.8 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 1.3 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.2 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 0.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.3 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.2 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 1.5 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 0.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.2 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.2 | 0.2 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.2 | 0.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.5 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 2.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.2 | 0.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 1.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 2.9 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.6 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.8 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.2 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 1.6 | GO:0002891 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.2 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.9 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.5 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.3 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 0.6 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 1.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.2 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.2 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.2 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 1.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 0.3 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 2.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.2 | GO:0055078 | cellular sodium ion homeostasis(GO:0006883) sodium ion homeostasis(GO:0055078) |
0.2 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.3 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.2 | 1.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.3 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.3 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 1.3 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.1 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.4 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.1 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 1.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 2.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 1.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.4 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 1.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.5 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.1 | 0.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.4 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.4 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.4 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 3.2 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.8 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 1.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 2.2 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.4 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 1.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.9 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.4 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.8 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.7 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.2 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0072124 | glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.5 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.4 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.1 | 0.1 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.1 | 0.5 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.1 | 0.4 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 2.8 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 3.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.7 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.1 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.1 | GO:0031223 | auditory behavior(GO:0031223) |
0.1 | 0.9 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 1.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 1.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.4 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 | 0.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.1 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.1 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.3 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 2.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.5 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 1.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.3 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 1.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 2.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 1.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0072224 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
0.1 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 1.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.5 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.1 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.3 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.3 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.1 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.3 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.4 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 4.7 | GO:1902402 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.4 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.2 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 1.1 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.5 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.3 | GO:1901623 | T cell chemotaxis(GO:0010818) regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) regulation of lymphocyte chemotaxis(GO:1901623) regulation of lymphocyte migration(GO:2000401) positive regulation of lymphocyte migration(GO:2000403) regulation of T cell migration(GO:2000404) positive regulation of T cell migration(GO:2000406) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.5 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 1.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.6 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 1.5 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.1 | 0.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.1 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.3 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.4 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.1 | 0.1 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.1 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.1 | 0.1 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 2.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.1 | 6.9 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.2 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 1.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.3 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.5 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 2.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.3 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.6 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 1.7 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 1.7 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.2 | GO:0051329 | mitotic interphase(GO:0051329) |
0.1 | 0.9 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.1 | 0.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.2 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.2 | GO:0052572 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.1 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.3 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 2.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.9 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 2.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.3 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 1.0 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.6 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.1 | 0.1 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.1 | 1.1 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 1.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.6 | GO:0043489 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.2 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0045117 | azole transport(GO:0045117) |
0.1 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.2 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.6 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.8 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.1 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.1 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.1 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.4 | GO:0050863 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.1 | 0.7 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.1 | 3.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 3.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.1 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.5 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 2.9 | GO:0097194 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.1 | 0.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.1 | 0.6 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 1.2 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.3 | GO:0021561 | facial nerve development(GO:0021561) |
0.1 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.7 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.7 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.2 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 3.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.2 | GO:0006991 | response to sterol depletion(GO:0006991) |
0.1 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.1 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.1 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0072243 | metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
0.1 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.1 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.1 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.1 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.2 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.6 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.2 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.1 | 0.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.3 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 1.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.8 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 2.4 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.2 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.1 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.1 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.1 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.0 | 0.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 1.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.5 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 1.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 2.3 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 2.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.0 | 0.3 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 5.7 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.0 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 4.7 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0032722 | positive regulation of chemokine production(GO:0032722) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.2 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.7 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 1.1 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.1 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 1.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 1.1 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.7 | GO:0061572 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.0 | 0.0 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.0 | 0.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.7 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.0 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.1 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.0 | 0.0 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 2.5 | GO:0034248 | regulation of cellular amide metabolic process(GO:0034248) |
0.0 | 5.1 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.1 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.6 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 1.0 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.6 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.0 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.1 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.1 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.0 | 0.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.2 | GO:0072595 | maintenance of protein location in nucleus(GO:0051457) maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 1.1 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.7 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.0 | 0.4 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.3 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.0 | 0.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 1.4 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.2 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.1 | GO:0035883 | enteroendocrine cell differentiation(GO:0035883) |
0.0 | 0.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 1.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.6 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.1 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:1903309 | negative regulation of chromatin modification(GO:1903309) |
0.0 | 0.2 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.1 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.0 | 0.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.2 | GO:0006241 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 3.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.3 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.2 | GO:1901862 | negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.1 | GO:2000258 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.0 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.2 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) ventral spinal cord development(GO:0021517) spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 3.0 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.5 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.0 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.1 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 1.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.2 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.2 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 1.9 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.0 | 0.1 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.0 | 0.0 | GO:0045913 | positive regulation of cellular carbohydrate metabolic process(GO:0010676) positive regulation of carbohydrate metabolic process(GO:0045913) |
0.0 | 0.0 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.2 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.2 | GO:0019184 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.0 | GO:0031281 | positive regulation of cyclase activity(GO:0031281) positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.5 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.3 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.4 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) regulation of neuron death(GO:1901214) |
0.0 | 0.1 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 3.5 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:0030826 | regulation of cGMP metabolic process(GO:0030823) regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.0 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.0 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.0 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.3 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.2 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.0 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.0 | 0.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.0 | 0.2 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.5 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.0 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.3 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.0 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.0 | 0.9 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.1 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.2 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.0 | 0.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 1.1 | GO:0050776 | regulation of immune response(GO:0050776) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 3.4 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 2.2 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 1.1 | GO:0070085 | glycosylation(GO:0070085) |
0.0 | 0.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:0001774 | microglial cell activation(GO:0001774) |
0.0 | 1.7 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.3 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.1 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.1 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.4 | GO:0030902 | hindbrain development(GO:0030902) |
0.0 | 1.1 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.1 | GO:0006027 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0016311 | dephosphorylation(GO:0016311) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 1.3 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.2 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.0 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.0 | GO:0098581 | detection of biotic stimulus(GO:0009595) detection of external biotic stimulus(GO:0098581) |
0.0 | 0.3 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.0 | 0.0 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.0 | 0.1 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0050670 | regulation of lymphocyte proliferation(GO:0050670) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.0 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.0 | 0.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0097028 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.3 | GO:0042384 | cilium assembly(GO:0042384) |
0.0 | 0.2 | GO:0055067 | monovalent inorganic cation homeostasis(GO:0055067) |
0.0 | 0.0 | GO:1901989 | positive regulation of cell cycle phase transition(GO:1901989) positive regulation of mitotic cell cycle phase transition(GO:1901992) |
0.0 | 0.0 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.0 | 0.1 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.0 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:0070227 | lymphocyte apoptotic process(GO:0070227) thymocyte apoptotic process(GO:0070242) |
0.0 | 0.0 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.3 | GO:0030163 | protein catabolic process(GO:0030163) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 5.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 1.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 1.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 1.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.5 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.3 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 0.5 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.3 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 3.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.5 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 1.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.9 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.4 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 2.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.3 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 1.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.4 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 0.9 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.0 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.7 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.0 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 2.6 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 1.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 3.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.1 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.7 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.5 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 1.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 1.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.4 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 2.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 3.5 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 4.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.2 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 1.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 2.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 1.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 1.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.7 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 2.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 2.1 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.3 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.5 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 3.4 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 4.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.4 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.5 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 2.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 6.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.1 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 1.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 2.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.8 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 2.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 10.0 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.2 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 2.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 4.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.6 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 2.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.5 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 2.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 1.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.3 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 1.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.5 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 4.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.0 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 4.2 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.0 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 1.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 1.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 21.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.8 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 1.1 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 2.9 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 4.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.3 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 1.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 2.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 47.8 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 6.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 3.0 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.1 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 1.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 2.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 7.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.4 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 2.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 10.1 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.0 | 1.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 76.2 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 2.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 3.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 2.7 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.0 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.0 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.0 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.0 | 0.5 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.1 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.0 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.0 | GO:0031967 | organelle envelope(GO:0031967) |
0.0 | 0.1 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 1.2 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 40.9 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0032982 | myosin filament(GO:0032982) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 1.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 7.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 1.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 1.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 1.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 0.8 | GO:0004527 | exonuclease activity(GO:0004527) |
0.4 | 1.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 2.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 0.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 0.9 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 2.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 1.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 4.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 6.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 1.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 2.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 1.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.7 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 1.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 2.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 2.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 2.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.2 | 0.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 3.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 1.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.9 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 0.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 3.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 2.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.6 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 8.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 4.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 1.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 2.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.8 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.8 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 1.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 1.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.7 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 1.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 4.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 2.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 4.3 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.9 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 1.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 3.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.6 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 5.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 1.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 1.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 1.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.6 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 1.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.7 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 1.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 2.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 2.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.4 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 1.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 2.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol 3-kinase activity(GO:0035004) |
0.1 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 4.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 2.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 2.2 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 1.1 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.6 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 2.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 1.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 1.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 3.1 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.1 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.3 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 3.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 2.4 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.3 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 1.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 12.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.4 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 1.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.1 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 1.5 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 2.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.4 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.3 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.3 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 1.1 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.3 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 3.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 2.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.4 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 1.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.3 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 1.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.2 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.4 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 3.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.7 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 0.3 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 22.1 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 1.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.5 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 1.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 1.1 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.8 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 2.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.1 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 2.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.2 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 1.0 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 48.3 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 7.5 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 5.8 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 1.3 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.7 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 1.7 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.6 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 2.7 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.0 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 1.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.0 | GO:0009975 | cyclase activity(GO:0009975) |
0.0 | 0.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.1 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 1.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 19.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 3.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 6.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 4.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 3.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 10.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 3.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 2.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 1.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 5.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 2.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 2.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 3.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 4.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 1.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 3.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 5.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 4.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 4.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.8 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 3.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 1.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 8.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 6.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 1.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 5.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 2.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 6.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.3 | 5.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 3.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 1.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 3.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 1.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 4.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 5.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 2.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 5.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 3.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 2.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 3.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 3.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 5.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 1.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 3.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 3.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 6.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 3.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.6 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 5.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 7.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.5 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.1 | 1.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 5.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 2.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 2.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 7.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 7.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 2.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 2.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.7 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.0 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 1.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.0 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 2.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 1.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 1.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 6.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.6 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.0 | 0.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 1.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 2.8 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |